Evidence map›Paper›PMID 36514678›Full record

ArticleRadiologia brasileira

Computed tomography assessment of body composition in patients with nonmetastatic breast cancer: what are the best prognostic markers?

José Carlos Oliveira Júnior, Thais Manfrinato Miola, Stefânia Maria Roman, Humberto Oliart-Guzmán, Vinícius Silva Oliveira, Juliana de Oliveira Souza, Fabiana Baroni Makdissi, Almir Galvão Vieira Bitencourt

Abstract read
In one paragraph

Article in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Is Adipose Tissue Inflammation the Culprit of Obesity-Associated Comorbidities?Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

José Carlos Oliveira JúniorA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0001-5015-1171
Thais Manfrinato MiolaA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0002-6554-6923
Stefânia Maria RomanA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0001-8038-6887
Humberto Oliart-GuzmánA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0002-1067-416X
Vinícius Silva OliveiraA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0003-3889-6124
Juliana de Oliveira SouzaA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0002-0018-7472
Fabiana Baroni MakdissiA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0002-4442-0870
Almir Galvão Vieira BitencourtA.C.Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0003-0192-9885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To correlate body composition measures, based on computed tomography (CT) analysis of muscle mass and adipose tissue, with disease-free survival in breast cancer patients. Materials and Methods: This single-center retrospective study included 262 female patients with nonmetastatic breast cancer. Body composition was assessed on a pretreatment CT scan (at the L3 level). The analysis included quantification of the areas of subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and skeletal muscle mass, as well as of the mean skeletal muscle density. The VAT/SAT ratio, skeletal mass index (SMI), and skeletal muscle gauge (SMG) were calculated. Results: Of the 262 patients evaluated, 175 (66.8%) were classified as overweight or obese on the basis of their body mass index. We observed low SMI in 35 patients (13.4%) and elevated VAT in 123 (46.9%). Disease-free survival was significantly shorter in the patients who underwent neoadjuvant chemotherapy ( Conclusion: Our results confirm that low SMG and the VAT/SAT ratio can be used as imaging biomarkers to assess prognosis in patients with nonmetastatic breast cancer.

Indexed as

Body compositionBreast neoplasmsPrognosisTomography, X-ray computed

Identifiers

PMID36514678
PMCPMC9743258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.